菩人丹超微粉对糖尿病大鼠视网膜ang-2 tnf-α表达的影响-effect of pu ren dan ultrafine powder on expression of ang - 2 tnf - α in retina of diabetic rats.docxVIP

  • 7
  • 0
  • 约3.99万字
  • 约 51页
  • 2018-07-28 发布于上海
  • 举报

菩人丹超微粉对糖尿病大鼠视网膜ang-2 tnf-α表达的影响-effect of pu ren dan ultrafine powder on expression of ang - 2 tnf - α in retina of diabetic rats.docx

菩人丹超微粉对糖尿病大鼠视网膜ang-2 tnf-α表达的影响-effect of pu ren dan ultrafine powder on expression of ang - 2 tnf - α in retina of diabetic rats

中文摘要佳,神经节细胞排列紊乱,细胞数量减少,可见细胞空泡样变、核固缩等现象。PRD治疗组视网膜内界膜表面粗糙欠平,轻度肿胀增厚、视网膜分层较清晰,神经节细胞排列轻度紊乱,细胞数量轻度减少。3.各组大鼠视网膜Ang-2的表达3.1SP免疫组织化学染色结果:Ang-2蛋白免疫阳性产物呈棕黄色颗粒状,表达位于细胞浆。Ang-2表达阳性细胞主要分布在大鼠视网膜神经节细胞层及内核层。与正常对照组相比糖尿病模型组胞浆Ang-2免疫阳性产物呈深棕黄色;PRD治疗组Ang-2免疫阳性产物表达较糖尿病模型组明显减弱,胞浆呈棕黄色。3.2采用MiVnt图像分析系统对免疫组化阳性表达面积进行定量分析结果:与正常对照组相比糖尿病模型组阳性表达面积明显增加(P<0.01);PRD治疗组与糖尿病模型组相比,阳性表达面积减少(P<0.01)。3.3Westernblot法检测Ang-2蛋白表达结果:与正常对照组比较,糖尿病模型组大鼠视网膜Ang-2蛋白表达明显升高(P<0.01);PRD治疗组大鼠视网膜Ang-2蛋白的表达与糖尿病模型组比较明显降低(P<0.01)。4.各组大鼠视网膜TNF-α的表达4.1Westernblot法检测TNF-α蛋白表达结果:与正常对照组比较,糖尿病模型组大鼠视网膜TNF-α蛋白的表达明显升高(P<0.01);PRD治疗组大鼠视网膜TNF-α蛋白的表达与糖尿病模型组比较明显降低(P<0.01)。4.2RT-PCR检测TNF-αmRNA表达结果:与正常对照组比较,糖尿病模型组大鼠视网膜TNF-αmRNA的表达明显升高(P<0.01);PRD治疗组大鼠视网膜TNF-αmRNA的表达与糖尿病模型组比较明显降低(P<0.01)。结论:PRD可以改善糖尿病大鼠视网膜病变,这一作用可能是通过下调糖尿病大鼠视网膜Ang-2和TNF-α的表达,从而减少视网膜微血管渗漏及病理性新生血管生成,发挥其对糖尿病大鼠视网膜微血管损伤的保护作用。关键词:菩人丹超微粉;糖尿病视网膜病变;血管生成素-2;肿瘤坏死因子-α;大鼠EffectsofPurendansuperfinepowderontheexpressionofAng-2andTNF-αinretinalofdiabetesratsABSTRACTPURPOSEThroughinginvestigatingtheeffectofpurendansuperfinepowderontheexpressionofangiopoietin-2(Ang-2)andtumornecrosisfactor-α(TNF-α)inretinalwithdiabetesrats,todiscusstheprotecteffectiveofPRDonthediabetesrats’retinalcapillarypathologicalchanges.METHODSThirtysixmaleWistarratsweredividedinto3groupsrandomly:normalcontrolgroup,diabeticmodelgroupandthePRDtreatmentgroup,eachgroupincludes12rats.Usetheintraperitonealinjectionof2%Streptozotocin(25mg/kg·d)onthePRDtreatmentgroupanddiabeticsmodelratsfor3dayscontinually,toestablishtypeⅡdiabetesratsmodel.Thebloodglucose≥16.7mmol/Lwastakenasastandard.Afterestablishingthemodelsuccessfully,thediabetesmodelgroupwasintragastricadministrationwithsolventswithoutPRD;andtheratsinPRDtreatmentgroupwereintragastricadministrationwithPRD(1.8g/kg/d)for12weeks.Theratsinnormalcontrolgroupwerebredasnormal.ONETOUCHbloodglucosemeterwasusedtodetectthebloodglucoseofratsineachgroup;thehematoxylin-eosin(HE)stainingwasusedtoobservehistopathologicalchangeinretinaofratsineachgroup;theSPimmunohistochemicalstainingandWe

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档